Xencor is Biotechnology in United States that focus on protein therapeutics business. Founded in 1997. They cover business area such as Xencor Inc, engineer monoclonal antibody, severe and life-threaten disease, unmet medical need, its XmAb technology platform, antibody product candidate, its portfolio, its revenue, research and development collaboration, license, its internally develop drug candidate.
1997
( 27 years old in 2024 )
Protein Therapeutics
-
111 West Lemon Avenue
2nd Floor
Monrovia, CA 91016
United States
Private
Xencor Incengineer monoclonal antibodysevere and life-threaten diseaseunmet medical needits XmAb technology platformantibody product candidateits portfolioits revenueresearch and development collaborationlicenseits internally develop drug candidate
* We use standard office opening hours in near Xencor's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Xencor is Biotechnology business from United States that founded in 1997 (27 years old in 2024), Xencor business is focusing on Protein Therapeutics.
Xencor headquarter office and corporate office address is located in 111 West Lemon Avenue 2nd Floor Monrovia, CA 91016 United States.
Xencor was founded in United States.
In 2024, Xencor is currently focus on protein therapeutics sector.
Above is snippet of Google Trends for "protein therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Xencor, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
